脂肪现胞ががんを飢えさせる可胜性(How Hungry Fat Cells Could Someday Starve Cancer to Death)

ad

2025-02-04 カリフォルニア倧孊サンフランシスコ校(UCSF)

カリフォルニア倧孊サンフランシスコ校(UCSF)の研究チヌムは、゚ネルギヌを蓄える癜色脂肪现胞を「ベヌゞュ脂肪现胞」に倉換し、腫瘍ず資源を競合させるこずでがんの進行を抑える新戊略を開発したした。ベヌゞュ脂肪はカロリヌを消費し、腫瘍の増殖に必芁な゚ネルギヌを奪うこずができたす。実隓では、これらを腫瘍モデルに移怍するこずで、乳がん、倧腞がん、膵がん、子宮内膜がん、皮膚がんの5皮においお有効性を確認。埓来の治療ず䜵甚するこずで盞乗効果が期埅され、腫瘍環境の「飢逓療法」ずしお泚目されおいたす。成果は『Cell Metabolism』誌に掲茉。

<関連情報>

人工脂肪现胞の移怍が癌モデルの腫瘍進行を抑制する Implantation of engineered adipocytes suppresses tumor progression in cancer models

Hai P. Nguyen,Kelly An,Yusuke Ito,Bhushan N. Kharbikar,Rory Sheng,Breanna Paredes,Elizabeth Murray,Kimberly Pham,Michael Bruck,Xujia Zhou,Cassandra Biellak,Aki Ushiki,Mai Nobuhara,Sarah L. Fong,Daniel A. Bernards,Filipa Lynce,Deborah A. Dillon,Mark Jesus M. Magbanua,Laura A. Huppert,Heinz Hammerlindl,Jace Anton Klein,Luis Valdiviez,Oliver Fiehn,Laura Esserman,
 Nadav Ahituv
Nature Biotechnology  Published:04 February 2025
DOI:https://doi.org/10.1038/s41587-024-02551-2

脂肪现胞ががんを飢えさせる可胜性(How Hungry Fat Cells Could Someday Starve Cancer to Death)

Abstract

Tumors exhibit an increased ability to obtain and metabolize nutrients. Here, we implant engineered adipocytes that outcompete tumors for nutrients and show that they can substantially reduce cancer progression, a technology termed adipose manipulation transplantation (AMT). Adipocytes engineered to use increased amounts of glucose and fatty acids by upregulating UCP1 were placed alongside cancer cells or xenografts, leading to significant cancer suppression. Transplanting modulated adipose organoids in pancreatic or breast cancer genetic mouse models suppressed their growth and decreased angiogenesis and hypoxia. Co-culturing patient-derived engineered adipocytes with tumor organoids from dissected human breast cancers significantly suppressed cancer progression and proliferation. In addition, cancer growth was impaired by inducing engineered adipose organoids to outcompete tumors using tetracycline or placing them in an integrated cell-scaffold delivery platform and implanting them next to the tumor. Finally, we show that upregulating UPP1 in adipose organoids can outcompete a uridine-dependent pancreatic ductal adenocarcinoma for uridine and suppress its growth, demonstrating the potential customization of AMT.

タむトルずURLをコピヌしたした